tweenvest

Korsana Biosciences, Inc. (NasdaqCM: KRSA)

Health Care · Biotechnology · US

$32.68

+3.25% today · +235.9% 1Y

Public summary
A free snapshot of Korsana Biosciences, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Korsana Biosciences, Inc. (NasdaqCM: KRSA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.49B and employs 19 people.

Over the last twelve months the share price has gained 235.9%, trading between 7.19 and 59.36.

Tweenvest scores Korsana Biosciences, Inc. across four factors: quality 74/100. Its strongest factor is quality.

KRSA price history

Nov 21, 2025 · 10.36Weekly closes 7.70 – 43.05Nov 16, 2026 · 32.68

Key figures

Market cap
$1.49B
Revenue (TTM)
—
P/E
—
EPS
-12.20
Dividend yield
—
Beta (5Y)
1.84
52-week high
$59.36
52-week low
$7.19
Avg volume (3M)
—
Shares outstanding
45.54M
Employees
19
Next earnings
—

About Korsana Biosciences, Inc.

Korsana Biosciences, Inc. is a clinical-stage biotechnology company developing therapies for neurodegenerative diseases. Its lead program, KRSA-028, is an investigational shuttled antibody targeting amyloid beta for the treatment of Alzheimer's disease. The company became publicly traded in September 2026 through a merger with Cyclerion Therapeutics, Inc.

ISIN
US23255M3034
Founded
2024
Listed since
Sep 9, 2026
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Zhuhai Trinomab Pharmaceutical Co., Ltd.SHSE: 688806$1.52BCN¥21.97-5.02%
Voronoi, Inc.KOSDAQ: A310210$1.51B₩111,000.00+1.19%
CanSino Biologics Inc.SEHK: 6185$1.50BHK$23.34-1.85%
AlvotechNasdaqGM: ALVO$1.50B$4.19-10.28%
Ab&B Bio-Tech CO., LTD. JSSEHK: 2627$1.47BHK$29.32-1.01%
Biotest GmbH & Co. KGaAHMSE: BIO0$1.46B€33.40-0.60%
uniQure N.V.NasdaqGS: QURE$1.42B$20.30-2.24%
Absci CorporationNasdaqGS: ABSI$1.41B$8.18+7.92%

Browse every Biotechnology company →